09/10/2019 55th EASD Annual Meeting in Barcelona, Spain.
Physiogenex will attend the 55th EASD Annual Meeting on September 17, 2019 in Barcelona.
Dr. François Briand, our Director of Research and Business Development, will present a poster during the Posters Sessions PS 037 (Diet, bugs and drugs) on Tuesday September 17, 2019 from 12pm to 1pm.
Poster: “Liraglutide shows better weight-loss and cardiometabolic benefits than lorcaserin and pioglitazone in a novel diet-induced obese rat model.”
Dr. Briand will be happy to discuss with you about your drug development projects.
Please Contact us if you wish to set up an appointment.
Physiogenex is a leading preclinical contract research organization providing non clinical services in metabolic disorders and complications.
We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We have a strong expertise on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis) and renal complications.